Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on January 1, 2000. The length of the article is 544 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Chiesi and Epigenesis enter license and development agreement for antisense oligonucleotide treatment of asthma.(Chiesi Farmaceutici, S.p.A., Epigenesis Pharmaceuticals Inc.)(Brief Article)
Publication: BIOTECH Patent News (Newsletter)
Date: January 1, 2000
Publisher: Biotech Patent News
Volume: 14 Issue: 1 Page: NA
Article Type: Brief Article
Distributed by Thomson Gale
This item is not eligible for Amazon Prime, but millions of other items are. Join Amazon Prime today. Already a member? Sign in.
| ||
|
|
 |
 |
 |
|
Save all season long on bestsellers, kids' books, holiday favorites and more in our Books Holiday Store. |
|
 |
|
 |
Editorial Reviews
Product Details
|
Suggested Tags from Similar Products( What's this?)Be the first one to add a relevant tag (keyword that's strongly related to this product).
|